Your session is about to expire
← Back to Search
Telehealth Behavioral Activation for Stroke Recovery (teleABLE Trial)
N/A
Waitlist Available
Led By Emily Kringle, PhD, OTR/L
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ambulatory with or without assistive device (assessed by Functional Independence Measure, mobility score ≥5)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 2 through week 7
Awards & highlights
teleABLE Trial Summary
This trial studies if an intervention can help stroke-related disability adults reduce their sedentary time, which can improve cardiovascular health. 10 participants will be assessed and monitored to see if the interventions are feasible and acceptable.
Who is the study for?
This trial is for adults who had a stroke within the last year, spend over 6 hours sitting on weekdays, can walk (with or without help), use video calls on a device, and have someone they see weekly. They can't join if in certain facilities, have severe cognitive issues, active cancer treatment, major depression, recent psychiatric hospitalization or substance abuse treatment.Check my eligibility
What is being tested?
The study tests teleABLE intervention via videoconferencing to reduce sedentary behavior post-stroke. Participants will be monitored and complete 12 sessions over 8 weeks. The goal is to determine if this approach is practical and well-received by participants.See study design
What are the potential side effects?
Since teleABLE involves behavioral activation through videoconferencing rather than medication or invasive procedures, traditional side effects are not expected. However, discomfort from wearing an activity monitor may occur.
teleABLE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can walk by myself or with help like a cane or walker.
teleABLE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 2 through week 7
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 2 through week 7
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of Treatment-Emergent Adverse Events
Participant Satisfaction
Secondary outcome measures
Change in Health-Related Quality of Life
Change in Participation Restrictions
Change in Sedentary Minutes
teleABLE Trial Design
1Treatment groups
Experimental Treatment
Group I: teleABLEExperimental Treatment1 Intervention
Participants will complete 12 teleABLE sessions via videoconferencing, guided by an intervention therapist and participant workbook.
Find a Location
Who is running the clinical trial?
University of MinnesotaLead Sponsor
1,377 Previous Clinical Trials
1,588,285 Total Patients Enrolled
37 Trials studying Stroke
50,887 Patients Enrolled for Stroke
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,833 Previous Clinical Trials
47,306,485 Total Patients Enrolled
85 Trials studying Stroke
537,495 Patients Enrolled for Stroke
University of Illinois at ChicagoOTHER
607 Previous Clinical Trials
1,559,345 Total Patients Enrolled
18 Trials studying Stroke
2,241 Patients Enrolled for Stroke
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger